Investment
Is Life Science REIT nearing its end?
LABS is exploring options including potential sale or wind-down after facing market challenges, with shares trading at a steep discount to NAV.
3 min read
Table of Contents
Written by
More from Life Sciences Real Estate
paid
How CROs and CDMOs navigate real estate decisions
Life science CDMOs balance real estate ownership (73 per cent) vs leasing (27 per cent) based on financial, operational, and strategic considerations.
5 min read
paid
Pharmaceutical companies and real estate: the rent versus buy decision
Pharmaceutical giants are transforming their real estate strategies. Industry leaders are shifting from traditional property ownership to strategic lease-ownership balancing for financial efficiency and flexibility.
5 min read
paid
Five examples of historic buildings transformed into life sciences hubs
Historic buildings across Europe are being repurposed into modern life sciences facilities, preserving heritage while supporting innovation.
5 min read